checkAd
    Startseite > Aktien > C4 Therapeutics > Nachrichten
    C4 Therapeutics Aktie
    4,8150
     
    USD
    -2,73 %
    -0,1350 USD
    Letzter Kurs 16:17:01 Nasdaq
    4,8000
     
    USD
    500 STK
    Geldkurs 16:17:23
    4,8100
     
    USD
    200 STK
    Briefkurs 16:17:23
    ISIN: US12529R1077 · WKN: A2QC0X · SYM: CCCC · USA

    Neueste Nachrichten

    C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    08.05.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    29.04.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
    09.04.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
    08.04.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics to Present New Preclinical Data on Highly Selective Orally Bioavailable BiDAC Degraders at the American Association for Cancer Research Annual Meeting 2024
    05.03.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
    04.03.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
    22.02.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted Protein Degradation Medicines
    09.01.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
    04.01.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    04.01.24 · globenewswire · C4 Therapeutics
    C4 Therapeutics to Host Webcast to Present New Dose Escalation Data from CFT7455 Phase 1 Study in Relapsed/Refractory Multiple Myeloma
    28.11.23 · globenewswire · C4 Therapeutics
    C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
    20.11.23 · globenewswire · C4 Therapeutics